Another option that was touched upon in the PR yesterday: A company like Medtronic or Boston scientific may be interested in MTA for coating their pacemakers or leads with a bactericidal drug like Brilacidin . These devices are just under the fat and subcutaneous tissue and can easily get infected In the USA over 1.5 million pacers are implanted annually with an infection rate of 1 to 2 percent. These complications could save tens of millions of healthcare dollars.